New Key Statistics Module, Z-Score and F-Score
NAS:PTPI Key Ratios
| Market Cap $ M | 2.98 |
| Enterprise Value $ M | 6.45 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.96 |
| Price/Sales | 0.56 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 1.14 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 4.00 |
| EPS (TTM) $ | -4.21 |
| Beneish M-Score | -4.92 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.53 |
| EV-to-EBITDA | -5.89 |
| PEG | -- |
| Shares Outstanding M | 10.01 |
| Net Margin (%) | -117.55 |
| Operating Margin % | -337.84 |
| Pre-tax Margin (%) | -117.55 |
| Quick Ratio | 0.74 |
| Current Ratio | 0.85 |
| ROA % (ttm) | -15.88 |
| ROE % (ttm) | -55.58 |
| ROIC % (ttm) | -83.79 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.50 |
PTPI Number of Guru Trades
PTPI Volume of Guru Trades
Gurus Latest Trades with NAS:PTPI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PTPI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Petros Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:PTPI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers